Treatment of Ringworm infection with Unani medicines Qurs Asfar and Roghan Narjeel

An Open-Label, Clinical Validation Study to Evaluate the Efficacy and Safety of Unani Pharmacopoeial formulations â?? Qurs Asfar and Roghan Narjeel in Qooba (Dermatophytosis)

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/05/033851

Enrollment

110

Registered

2021-05-28

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B359- Dermatophytosis, unspecified

Interventions

Intervention1: Qurs Asfar and Roghan Narjeel: 1Tablet (775mg) twice daily to be taken orally with water and 1ml oil locally on affected part twice daily for 6 weeks respectively Control Intervention1:

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients of either sex in the age group of 18-65 years. 2. Subjects confirmed by direct microscopy 3. Clinical signs and symptoms suggestive of fungal infection

Exclusion criteria

Exclusion criteria: 1. Subjects on topical treatment within 2 weeks prior to entry into the study 2. Subjects on systemic therapy within 4 weeks prior to entry into the study 3. Subjects with Tineacapitis (tinea of scalp), Onychomycosis (tinea of nails) and Tineabarbae (tinea of beard) 4. Known cases of allergy to any ingredients of the study drug. 5. Subjects with history of diabetes mellitus and systemic illnessrequiring long-term treatment. 6. Lactating and pregnant women

Design outcomes

Primary

Measure	Time frame
Improvement in signs and symptoms of Qooba (Dermatophytosis)Timepoint: 2weeks	—

Secondary

Measure	Time frame
Haematological and biochemical assessment for safety assessment Timepoint: Investigations will be done at baseline and end of treatment	—

Countries

India

Contacts

Public ContactDr Pradeep Kumar

Central Council for Research in Unani Medicine (CCRUM)

ccrum507@rediffmail.com9213511298

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026